| Ashlee Pichette, CRNA | |
|
1638 Owen Dr, Fayetteville, NC 28304-3424 | |
| (910) 615-4000 | |
| Not Available |
| Full Name | Ashlee Pichette |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 1638 Owen Dr, Fayetteville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295246874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 5790 (North Carolina) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 119931 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Cary Hospital | Cary, NC | Hospital |
| Rex Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cumberland County Hospital System Inc | 1850204041 | 455 |
| American Anesthesiology Of North Carolina Pllc | 2961316450 | 383 |
| East Carolina Anesthesia Associates Pllc | 5092720813 | 464 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
| Entity Name | Cumberland County Hospital System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881946242 PECOS PAC ID: 1850204041 Enrollment ID: O20031112000693 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
| Entity Name | American Anesthesiology Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053677195 PECOS PAC ID: 2961316450 Enrollment ID: O20031229000004 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
| Entity Name | East Carolina Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205996519 PECOS PAC ID: 5092720813 Enrollment ID: O20060215000791 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
| Entity Name | Anesthesia Care Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609833474 PECOS PAC ID: 7012937105 Enrollment ID: O20090813000373 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashlee Pichette, CRNA 519 Kimloch Dr, Garner, NC 27529-5121 Ph: () - | Ashlee Pichette, CRNA 1638 Owen Dr, Fayetteville, NC 28304-3424 Ph: (910) 615-4000 |
News Archive
The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).
Cognizant today announced that it is working with HTH Worldwide, a global technology-based health services and information company, to enable its members to maximize the use of mobile technology for managing healthcare needs more effectively while traveling abroad. As part of the engagement, Cognizant is helping HTH Worldwide transform its mobile footprint through an enterprise mobile platform to support the company's rapidly growing business and further strengthen its leadership position in mobile medical assistance services.
Medulloblastomas are the most common malignant brain tumors of childhood, with 40 to 50 percent overall mortality. One of the greatest challenges in treating them is that they vary substantially from patient to patient. In the largest genomic study of human medulloblastomas to date, researchers from Children's Hospital Boston, together with collaborators, have identified six subtypes with distinct molecular "fingerprints" that will improve doctors' ability to direct and individualize treatment.
We often make quick strategic decisions to attack an opponent or defend our position, yet how we make them is not well understood. Now, researchers at the RIKEN Brain Science Institute in Japan have pinpointed specific brain regions related to this process by examining neural activity in people playing shogi, a Japanese form of chess.
StemCells, Inc. announced today that it has initiated a second clinical trial of its HuCNS-SC product candidate (purified human neural stem cells) in neuronal ceroid lipofuscinosis (NCL, also often referred to as Batten disease), a fatal neurodegenerative disorder in children.
› Verified 1 days ago
Mrs. Leesa Davis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 | |
Mrs. Miriah Catherine Adams, RN Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5132 | |
Dr. Jonathan Ray Hall, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2053 Valleygate Dr Ste 102, Fayetteville, NC 28304 Phone: 910-323-3757 | |
Edelrose Fortea Bacanto, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 805-509-7556 | |
Miss Jennifer Shattuck, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 | |
Jennifer Myles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-615-5132 Fax: 910-321-6236 | |
Mrs. Debbie Morales, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1638 Owen Dr, Fayetteville, NC 28304 Phone: 910-609-6440 Fax: 910-609-5365 |